Author Archive: BIOtechNOW Editor

Biopharma Companies Fight Tropical Diseases to Improve Global Health

International

Neglected tropical diseases (NTDs) are a group of devastating viral, bacterial, and parasitic diseases that predominantly burden individuals and communities living in poverty. NTDs received the moniker “neglected” due to the lack of attention they have received from the global biopharmaceutical community, and the resultant dearth of products available to prevent, diagnose, and treat them. This has been changing, though – Knight Therapeutics Inc. developed a drug to treat leishmaniasis (Impavido®) in 2014, Sanofi Pasteur Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,

Biomarkets: Looking For The Hole In The Donut

synthetic biology

This piece by Allan L. Shaw was originally published in Life Science Leader. The biopharma sector has enjoyed increased market success over the last few years. And while some may be tempted to bask in the optimistic “bio-euphoria,” others question whether the industry might be in the midst of a market bubble. What led to this current period of biopharma success, despite the industry’s inherent risks (e.g. scientific, clinical, regulatory, and commercial)? Several factors contributed Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

Why I packed my bag and headed to NASDA 2015 in Hawaii

Lorie Farrell

As the head wrangler and ringleader for Hawaii Farmers & Ranchers United, an agriculture alliance based on Hawaii Island, it made sense to go and show support for Scott Enright; Hawaii’s Chair of the Department of Agriculture. It would have been remiss to pass up this opportunity to attend this annual convention full of Agriculture thought leaders. Due to the cost I had only planned on attending for one day but fate intervened and I Read More >

Food And Agriculture  |  Leave a comment  |  Email This Post
Tags: , , ,

Warning: Don’t Let Bio-Euphoria Distract You from Being Disciplined

DNA

This piece by Allan L. Shaw was originally published in Life Science Leader. We currently in a period I call “bio-euphoria,” in which the biopharmaceutical industry is experiencing growth in almost every area from market performance to patient-focused legislation. In parallel to this positive momentum, there has also been a notable shift in management and operational strategy by Big Pharma companies in an attempt to keep evolving with the market. These companies are taking creative Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

Papayas in Paradise: Super powered fruit!

Lorie Farrell

As I drive into the fields in Keaau, I’m struck by the peaceful surroundings, the fields filled with growing papaya trees loaded with fruit. You can tell their age by how tall they are. At two years old, they’re about 10 feet tall and will grow another 10 feet per year until they reach approximately 40 feet tall; a height that is too tall to pick safely. The Rainbow papaya is a beautiful tree that Read More >

Food And Agriculture  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,